Literature DB >> 26749572

GSK3β isoform-selective regulation of depression, memory and hippocampal cell proliferation.

M Pardo1,2, E Abrial1,2, R S Jope1,2, E Beurel1,2.   

Abstract

Abnormally active glycogen synthase kinase-3 (GSK3) contributes to pathological processes in multiple psychiatric and neurological disorders. Modeled in mice, this includes increasing susceptibility to dysregulation of mood-relevant behaviors, impairing performance in several cognitive tasks and impairing adult hippocampal neural precursor cell (NPC) proliferation. These deficits are all evident in GSK3α/β knockin mice, in which serine-to-alanine mutations block the inhibitory serine phosphorylation regulation of both GSK3 isoforms, leaving GSK3 hyperactive. It was unknown if both GSK3 isoforms perform redundant actions in these processes, or if hyperactivity of one GSK3 isoform has a predominant effect. To test this, we examined GSK3α or GSK3β knockin mice in which only one isoform was mutated to a hyperactive form. Only GSK3β, not GSK3α, knockin mice displayed heightened vulnerability to the learned helplessness model of depression-like behavior. Three cognitive measures impaired in GSK3α/β knockin mice showed differential regulation by GSK3 isoforms. Novel object recognition was impaired in GSK3β, not in GSK3α, knockin mice, whereas temporal order memory was not impaired in GSK3α or GSK3β knockin mice, and co-ordinate spatial processing was impaired in both GSK3α and GSK3β knockin mice. Adult hippocampal NPC proliferation was severely impaired in GSK3β knockin mice, but not impaired in GSK3α knockin mice. Increased activity of GSK3β, in the absence of overexpression or disease pathology, is sufficient to impair mood regulation, novel object recognition and hippocampal NPC proliferation, whereas hyperactive GSK3α individually does not impair these processes. These results show that hyperactivity of the two GSK3 isoforms execute non-redundant effects on these processes.
© 2016 John Wiley & Sons Ltd and International Behavioural and Neural Genetics Society.

Entities:  

Keywords:  Cognition; depression; glycogen synthase kinase-3; neurogenesis; novel object recognition

Mesh:

Substances:

Year:  2016        PMID: 26749572      PMCID: PMC4777651          DOI: 10.1111/gbb.12283

Source DB:  PubMed          Journal:  Genes Brain Behav        ISSN: 1601-183X            Impact factor:   3.449


  32 in total

1.  Spatial learning deficit in transgenic mice that conditionally over-express GSK-3beta in the brain but do not form tau filaments.

Authors:  Félix Hernández; José Borrell; Carmen Guaza; Jesús Avila; José J Lucas
Journal:  J Neurochem       Date:  2002-12       Impact factor: 5.372

2.  Full reversal of Alzheimer's disease-like phenotype in a mouse model with conditional overexpression of glycogen synthase kinase-3.

Authors:  Tobias Engel; Félix Hernández; Jesús Avila; José J Lucas
Journal:  J Neurosci       Date:  2006-05-10       Impact factor: 6.167

3.  GSK3beta, a centre-staged kinase in neuropsychiatric disorders, modulates long term memory by inhibitory phosphorylation at serine-9.

Authors:  I Dewachter; L Ris; T Jaworski; C M Seymour; A Kremer; P Borghgraef; H De Vijver; E Godaux; F Van Leuven
Journal:  Neurobiol Dis       Date:  2009-04-18       Impact factor: 5.996

Review 4.  Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases.

Authors:  Eleonore Beurel; Steven F Grieco; Richard S Jope
Journal:  Pharmacol Ther       Date:  2014-11-27       Impact factor: 12.310

5.  Lentivirally mediated GSK-3β silencing in the hippocampal dentate gyrus induces antidepressant-like effects in stressed mice.

Authors:  Naoto Omata; Chi-Tso Chiu; Pablo R Moya; Yan Leng; Zhifei Wang; Joshua G Hunsberger; Peter Leeds; De-Maw Chuang
Journal:  Int J Neuropsychopharmacol       Date:  2010-07-07       Impact factor: 5.176

Review 6.  GSK-3 inhibitors: a ray of hope for the treatment of Alzheimer's disease?

Authors:  Ana Martinez; Daniel I Perez
Journal:  J Alzheimers Dis       Date:  2008-10       Impact factor: 4.472

Review 7.  Glycogen synthase kinase-3 inhibitors: Rescuers of cognitive impairments.

Authors:  Margaret K King; Marta Pardo; Yuyan Cheng; Kimberlee Downey; Richard S Jope; Eléonore Beurel
Journal:  Pharmacol Ther       Date:  2013-07-31       Impact factor: 12.310

8.  Blocked inhibitory serine-phosphorylation of glycogen synthase kinase-3alpha/beta impairs in vivo neural precursor cell proliferation.

Authors:  Tae-Yeon Eom; Richard S Jope
Journal:  Biol Psychiatry       Date:  2009-06-11       Impact factor: 13.382

9.  Impairments in cognition and neural precursor cell proliferation in mice expressing constitutively active glycogen synthase kinase-3.

Authors:  Marta Pardo; Margaret K King; Emma Perez-Costas; Miguel Melendez-Ferro; Ana Martinez; Eleonore Beurel; Richard S Jope
Journal:  Front Behav Neurosci       Date:  2015-03-04       Impact factor: 3.558

10.  Abnormalities in brain structure and behavior in GSK-3alpha mutant mice.

Authors:  Oksana Kaidanovich-Beilin; Tatiana V Lipina; Keizo Takao; Matthijs van Eede; Satoko Hattori; Christine Laliberté; Mustafa Khan; Kenichi Okamoto; John W Chambers; Paul J Fletcher; Katrina MacAulay; Bradley W Doble; Mark Henkelman; Tsuyoshi Miyakawa; John Roder; James R Woodgett
Journal:  Mol Brain       Date:  2009-11-19       Impact factor: 4.041

View more
  26 in total

1.  Ciliary neurotrophic factor signaling in the rat orbitofrontal cortex ameliorates stress-induced deficits in reversal learning.

Authors:  Milena Girotti; Jeri D Silva; Christina M George; David A Morilak
Journal:  Neuropharmacology       Date:  2019-09-22       Impact factor: 5.250

2.  Cotinine administration improves impaired cognition in the mouse model of Fragile X syndrome.

Authors:  Marta Pardo; Eleonore Beurel; Richard S Jope
Journal:  Eur J Neurosci       Date:  2016-11-12       Impact factor: 3.386

Review 3.  Neuroimaging genomic studies in major depressive disorder: A systematic review.

Authors:  Hui-Feng Zhang; David Mellor; Dai-Hui Peng
Journal:  CNS Neurosci Ther       Date:  2018-02-23       Impact factor: 5.243

4.  Prenatal Alcohol Exposure Leads to Enhanced Serine 9 Phosphorylation of Glycogen Synthase Kinase-3β (GSK-3β) in the Hippocampal Dentate Gyrus of Adult Mouse.

Authors:  Lee Anna Cunningham; Jessie Newville; Lu Li; Phillip Tapia; Andrea M Allan; C Fernando Valenzuela
Journal:  Alcohol Clin Exp Res       Date:  2017-10-03       Impact factor: 3.455

5.  (+)-Naloxone blocks Toll-like receptor 4 to ameliorate deleterious effects of stress on male mouse behaviors.

Authors:  Eva M Medina-Rodriguez; Kenner C Rice; Eléonore Beurel; Richard S Jope
Journal:  Brain Behav Immun       Date:  2020-08-26       Impact factor: 7.217

6.  Glycogen synthase kinase-3 inhibition rescues sex-dependent contextual fear memory deficit in human immunodeficiency virus-1 transgenic mice.

Authors:  Shamsudheen Moidunny; Michael A Benneyworth; David J Titus; Eleonore Beurel; Udhghatri Kolli; Joyce Meints; Richa Jalodia; Sundaram Ramakrishnan; Coleen M Atkins; Sabita Roy
Journal:  Br J Pharmacol       Date:  2020-11-23       Impact factor: 8.739

7.  Glycogen Synthase Kinase 3β in the Ventral Hippocampus is Important for Cocaine Reward and Object Location Memory.

Authors:  Jeffrey L Barr; Xiangdang Shi; Michael Zaykaner; Ellen M Unterwald
Journal:  Neuroscience       Date:  2019-11-26       Impact factor: 3.590

Review 8.  Inflammation and Insulin Resistance as Risk Factors and Potential Therapeutic Targets for Alzheimer's Disease.

Authors:  Angeles Vinuesa; Carlos Pomilio; Amal Gregosa; Melisa Bentivegna; Jessica Presa; Melina Bellotto; Flavia Saravia; Juan Beauquis
Journal:  Front Neurosci       Date:  2021-04-23       Impact factor: 4.677

9.  Unravelling the GSK3β-related genotypic interaction network influencing hippocampal volume in recurrent major depressive disorder.

Authors:  Becky Inkster; Andy Simmons; James H Cole; Erwin Schoof; Rune Linding; Tom Nichols; Pierandrea Muglia; Florian Holsboer; Philipp G Sämann; Peter McGuffin; Cynthia H Y Fu; Kamilla Miskowiak; Paul M Matthews; Gwyneth Zai; Kristin Nicodemus
Journal:  Psychiatr Genet       Date:  2018-10       Impact factor: 2.458

10.  Resveratrol Protects SH-SY5Y Cells Against Oleic Acid-Induced Glucolipid Metabolic Dysfunction and Cell Injuries Via the Wnt/β-Catenin Signalling Pathway.

Authors:  Jing-Xian Xu; Ke Fang; Xin-Ran Gao; Sen Liu; Jin-Fang Ge
Journal:  Neurochem Res       Date:  2021-07-14       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.